Artificial Intelligence-Guided Neuromodulation in Heart Failure with Preserved and Reduced Ejection Fraction: Mechanisms, Evidence, and Future Directions. [PDF]
Ansari RA+11 more
europepmc +1 more source
MR‐Guidance of Gene Therapy for Brain Diseases: Moving From Palliative Treatment to Cures
ABSTRACT Regulatory bodies in the U.S. and Europe recently approved a gene therapy for aromatic L‐amino acid decarboxylase (AADC) deficiency, a rare neurologic disorder where a genetic mutation prevents dopamine production in the brain. Affected children fail to develop normal motor and cognitive functions.
Dalton H. Bermudez+2 more
wiley +1 more source
Efficacy and Safety of Sacral Neuromodulation (Interstim®) for the Treatment of Refractory Overactive Bladder Symptoms and Chronic Pelvic Pain [PDF]
Jin Woo Chung+2 more
openalex +1 more source
Neuromodulation Interventions for Language Deficits in Alzheimer's Disease: Update on Current Practice and Future Developments. [PDF]
Chen F, Nie Y, Kuang C.
europepmc +1 more source
Expecting the Unexpected: Modeling of Neuromodulation
Michael E. Hasselmo
openalex +1 more source
Defining the Role of Astrocytes in Neuromodulation [PDF]
Nicolas X. Tritsch, Dwight E. Bergles
openalex +1 more source
ABSTRACT Background Ayahuasca is an Amazonian psychedelic brew that contains dimethyltryptamine (DMT) and beta carbolines. Prolonged use has shown changes in cognitive‐behavioral tasks, and in humans, there is evidence of changes in cortical thickness and an increase in neuroplasticity factors that could lead to modifications in functional neural ...
Lucas Rego Ramos+2 more
wiley +1 more source
How sacral nerve stimulation neuromodulation works
Wendy W.J. de Leng+1 more
openalex +1 more source
Abstract Objectives Disorders of gut–brain interaction (DGBI) are increasing in prevalence; however, diagnosis remains challenging in the setting of organic diseases. While adult studies have shown overlap between DGBI and celiac disease (CeD), no United States studies have assessed DGBI prevalence using Rome IV criteria in pediatric CeD.
Andrew Krueger+5 more
wiley +1 more source
Advancements in invasive and non-invasive neuromodulation for Parkinson's disease: current findings and future directions. [PDF]
Koirala N+3 more
europepmc +1 more source